Kyverna Therapeutics, Inc. (KYTX)
8.88
-0.21
(-2.31%)
USD |
NASDAQ |
Mar 17, 13:09
Kyverna Therapeutics Total Liabilities (Quarterly) : 35.21M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 899.65M |
| CorMedix, Inc. | 472.32M |
| Castle Biosciences, Inc. | 138.34M |
| EyePoint Plc | 57.88M |
| Vistagen Therapeutics, Inc. | 14.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 187.16M |
| Shareholders Equity (Quarterly) | 151.95M |
| Debt to Equity Ratio | 0.0331 |
| Current Ratio | 5.164 |
| Net Debt Paydown Yield | 0.38% |